Transcatheter Heart Valve Replacement and Repair Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Valves are a crucial part of the heart that maintains the blood flow through the heart. When the heart valves are damaged or diseased, they are repaired or replaced depending on the condition. Newly developed techniques involve less invasive procedures that are used to replace or repair the heart. Valve repair can be carried out on congenital valves defect, whereas the valve replacement is carried out on severe valve damage that involves the aortic or mitral valve. Transcatheter heart valve implantation is a minimally invasive surgical procedure that replaces the heart valve with a prosthetic valve to treat severe aortic stenosis and mitral regurgitation. Two types of valves are used for replacement, i.e., mechanical valves and biological valves. The mechanical valve is made of different materials such as plastic, carbon, and metal. In contrast, the biological valve is made from the human tissue of a donated heart or the tissue of an animal. It is primarily used in geriatric patients and needs to be replaced every ten years.

MARKET SCOPE

The "Global Transcatheter Heart Valve Replacement and Repair Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the transcatheter heart valve replacement and repair market with detailed market segmentation by product, procedure, application, end user, and geography. The report provides key statistics on the market status of the leading transcatheter heart valve replacement and repair market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•  Based on product, the global transcatheter heart valve replacement and repair market is segmented into transcatheter aortic valve replacement, transcatheter mitral valve repair and replacement, and transcatheter pulmonary valve replacement.
  
•  Based on procedure, the market is segmented into heart valve repair, and heart valve replacement.
  
•  Based on application, the market is segmented into aortic valvular heart disease, mitral valvular heart disease, and pulmonary valvular heart disease.
  
•  On the basis of end-users, the market is bifurcated into hospitals, cardiac catheterization laboratory, and ambulatory surgical centers.
  

MARKET DYNAMICS

Drivers:

•  Rise in the incidence of severe mitral regurgitation and severe aortic stenosis disorders.
  
•  Rise in the demand for minimal invasive procedure for high risk patients.
  
•  Growing technological advancements in the transcatheter heart valves.
  
•  Robust research & developments in the transcatheter heart valves.
  
•  Increase in the percutaneous transcatheter prosthetic valve implantation worldwide.
  

Restraints:

•  Long regulatory approval times.
  
•  High costs associated with transcatheter heart valves.
  
•  Risk associated with procedure.
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The transcatheter heart valve replacement and repair market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the transcatheter heart valve replacement and repair market in these regions.

IMPACT OF COVID-19 ON TRANSCATHETER HEART VALVE REPLACEMENT AND REPAIR MARKET

COVID-19 initially began in Wuhan (China) in December 2019, and till now, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The increasing prevalence of COVID-19 has affected the growth of the market. It halted imports, supply chain crisis, limited workforce, and lack of raw material availability affected the market growth. The pandemic has put an enormous strain on healthcare systems and intensive care unit capacity, leading to the cancelation of most elective procedures, including transcatheter aortic valve replacement (TAVR) and rescheduling of non-emergency procedures, and had a negative impact on the market. However, the upliftment of imposed restrictive measures will help the market witness growth in the forecast period.

MARKET PLAYERS

The report covers key developments in the transcatheter heart valve replacement and repair market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from transcatheter heart valve replacement and repair market are anticipated to have lucrative growth opportunities in the future with the rising demand for transcatheter heart valve replacement and repair in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the transcatheter heart valve replacement and repair market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•  Abbott Laboratories
  
•  Edwards Lifesciences Corporation
  
•  Boston Scientific Corporation
  
•  Medtronic, Inc.
  
•  CryoLife, Inc.
  
•  St. Jude Medical, Inc.
  
•  Braile Biomedica
  
•  JenaValve Technology
  
•  Oneovasc
  
•  LivaNova
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Transcatheter Heart Valve Replacement and Repair Report Scope